NCT04652375View on ClinicalTrials.gov

Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures

NACompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 26, 2022

Study Completion Date

July 26, 2022

Conditions
Coronary Artery Bypass Graft SurgeryAortic Valve Replacement
Interventions
OTHER

Albumin Solution

Participants will receive Albumin solution for fluid resuscitation post-surgery.

OTHER

Lactated Ringer's Solution

Participants will receive Lactated Ringer's solution for fluid resuscitation post-surgery.

Trial Locations (1)

06510

Yale New Haven Hospital, New Haven

All Listed Sponsors
lead

Yale University

OTHER